Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CDKN2C Antikörper (AA 1-68)

CDKN2C Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7148889
  • Target Alle CDKN2C Antikörper anzeigen
    CDKN2C (Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C))
    Bindungsspezifität
    • 15
    • 13
    • 9
    • 4
    • 2
    • 1
    • 1
    • 1
    AA 1-68
    Reaktivität
    • 59
    • 17
    • 11
    • 2
    • 1
    Human
    Wirt
    • 53
    • 6
    • 1
    Kaninchen
    Klonalität
    • 53
    • 6
    Polyklonal
    Konjugat
    • 25
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CDKN2C Antikörper ist unkonjugiert
    Applikation
    • 47
    • 22
    • 22
    • 13
    • 13
    • 11
    • 5
    • 3
    • 3
    • 1
    Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human Cyclin-dependent kinase 4 inhibitor C protein (1-68AA)
    Isotyp
    IgG
    Top Product
    Discover our top product CDKN2C Primärantikörper
  • Applikationshinweise
    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    CDKN2C (Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C))
    Andere Bezeichnung
    CDKN2C (CDKN2C Produkte)
    Synonyme
    CDKN2C antikoerper, p18 antikoerper, ink4c antikoerper, p18-ink4c antikoerper, INK4C antikoerper, p18-INK4C antikoerper, C77269 antikoerper, INK4c antikoerper, INK4d antikoerper, p18INK4c antikoerper, cyclin dependent kinase inhibitor 2C antikoerper, cyclin-dependent kinase inhibitor 2C antikoerper, cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) antikoerper, CDKN2C antikoerper, cdkn2c antikoerper, Cdkn2c antikoerper
    Hintergrund

    Background: Interacts strongly with CDK6, weakly with CDK4. Inhibits cell growth and proliferation with a correlated dependence on endogenous retinoblastoma protein RB.

    Aliases: CDK6 inhibitor p18 antibody, CDKN 2C antibody, CDKN 6 antibody, Cdkn2c antibody, CDKN6 antibody, CDN2C_HUMAN antibody, Cyclin dependent inhibitor antibody, Cyclin dependent kinase 4 inhibitor C antibody, Cyclin dependent kinase 6 inhibitor antibody, Cyclin dependent kinase 6 inhibitor p18 antibody, Cyclin dependent kinase inhibitor 2C (p18 inhibits CDK4) antibody, Cyclin dependent kinase inhibitor 2C antibody, Cyclin-dependent kinase 4 inhibitor C antibody, Cyclin-dependent kinase 6 inhibitor antibody, INK4C antibody, OTTHUMP00000046546 antibody, p18 antibody, p18 inhibits CDK4 antibody, p18 INK4c antibody, p18 INK6 antibody, p18-INK4c antibody, p18-INK6 antibody

    UniProt
    P42773
    Pathways
    Zellzyklus, Mitotic G1-G1/S Phases
Sie sind hier: